by KJ McElrath | Aug 6, 2018 | Xarelto |
A “real world” analysis of records on over 11,000 patients around the world who suffer from atrial...
by KJ McElrath | Jul 6, 2018 | Xarelto |
A “real world” analysis of records on over 11,000 patients around the world who suffer from atrial...
by KJ McElrath | Oct 25, 2017 | Xarelto |
One of the big selling points for the anticoagulant Xarelto (rivaroxaban) was the claim that,...
by KJ McElrath | Oct 12, 2017 | Xarelto |
A recent clinical study intended to demonstrate the superiority of Xarelto (rivaroxaban) to...
by KJ McElrath | Sep 6, 2017 | Xarelto |
Once again, a jury has sided with corporate defendants Bayer and Johnson & Johnson’s...
by KJ McElrath | Aug 8, 2017 | Xarelto |
As the third lawsuit against Janssen Pharmaceuticals and Bayer AG gets underway, the Institute for...
